Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized furosemide for mechanically ventilated adults with ARDS
ISRCTN16516753Phase 2Completed
- Sponsor
- King Saud Medical City
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute respiratory distress syndrome (ARDS) comparing Nebulized furosemide with Placebo saline (2 arms). Primary endpoint: 28-day mortality. Started Apr 2025; status: completed.
02
Drugs
furosemide
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on ISRCTN16516753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16516753.